BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6314011)

  • 1. Binding characteristics of 3H-dihydroalprenolol to beta-adrenoceptors of rat heart treated with neuraminidase.
    Nagatomo T; Sasaki M; Tsuchihashi H; Imai S
    Jpn J Pharmacol; 1983 Aug; 33(4):851-7. PubMed ID: 6314011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding characteristics of [3H]dihydroalprenolol to beta-adrenergic receptors of rat brain: comparison with those of rat heart treated with neuraminidase.
    Tsuchihashi H; Sasaki M; Nagatomo T
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3972-6. PubMed ID: 3004753
    [No Abstract]   [Full Text] [Related]  

  • 3. The (--)[3H]dihydroalprenolol binding to rat adipocyte membranes: an explanation of curvilinear Scatchard plots and implications for quantitation of beta-adrenergic sites.
    Dax EM; Partilla JS; Gregerman RI
    J Lipid Res; 1982 Sep; 23(7):1001-8. PubMed ID: 6292316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the (--)-[3H]-dihydroalprenolol binding to beta-adrenoceptors and transmembrane 86Rb efflux of the BC3H1 nonfusing muscle cell line.
    Mauger JP; Worcel M
    Br J Pharmacol; 1980 Apr; 68(4):731-9. PubMed ID: 6103725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic receptors in guinea-pig liver plasma membranes and thermal lability of [3H]dihydroalprenolol binding sites.
    Kawai Y; Graham SM; Yoshioka H; Arinze IJ
    Biochem Pharmacol; 1986 Dec; 35(24):4387-93. PubMed ID: 3024648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]dihydroalprenolol binding in the rat brainstem.
    Stone EA; U'Prichard DC
    Eur J Pharmacol; 1981 Oct; 75(2-3):159-61. PubMed ID: 6119217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of skeletal muscle beta-adrenergic receptors coupled to adenylate cyclase.
    Reddy NB; Engel WK
    Biochim Biophys Acta; 1979 Jul; 585(3):343-59. PubMed ID: 226166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of (-)-[3H]dihydroalprenolol binding to intact and broken cell preparations of human peripheral blood lymphocytes.
    Meurs H; van den Bogaard W; Kauffman HF; Bruynzeel PL
    Eur J Pharmacol; 1982 Nov; 85(2):185-94. PubMed ID: 6295780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of [3H]-dihydroalprenolol and [3H]-acetobutolol to human blood platelets is not related to occupancy of beta-adrenoceptors.
    Kerry R; Scrutton MC
    Thromb Res; 1983 Mar; 29(6):583-94. PubMed ID: 6304932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
    Sawutz DG; Sylvestre D; Homcy CJ
    J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites.
    Landi M; Bianchetti A; Croci T; Manara L
    Biochem Pharmacol; 1992 Aug; 44(4):665-72. PubMed ID: 1354964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic receptor subtypes in iris-ciliary body of rabbits.
    Schmitt CJ; Gross DM; Share NN
    Graefes Arch Clin Exp Ophthalmol; 1984; 221(4):167-70. PubMed ID: 6142847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature dependence of [3H]dihydroalprenolol binding in rat myocardium.
    Winek R; Bhalla R
    Eur J Pharmacol; 1982 Jan; 77(2-3):89-94. PubMed ID: 6277664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-receptor blocking potencies of the three newly synthesized beta-adrenergic antagonists (S-596, K-351, N-696) as assessed with the radioligand binding assay method in rat cardiac muscle membrane treated with neuraminidase.
    Nagatomo T; Tsuchihashi H; Sasaki M; Nakagawa Y; Nakahara H; Imai S
    Jpn J Pharmacol; 1984 Feb; 34(2):249-54. PubMed ID: 6205196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of beta-adrenergic receptors in the rat vas deferens using [3H]-dihydroalprenolol binding.
    Chang RS; Lotti VJ
    Life Sci; 1983 May; 32(22):2603-9. PubMed ID: 6134224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of beta-adrenergic receptors in rat ovary.
    Laszlovszky I; Erdö SL
    Eur J Pharmacol; 1983 Dec; 96(1-2):101-4. PubMed ID: 6141056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocyte beta-adrenergic receptors. Identification and subcellular localization by (-)-[3H]dihydroalprenolol binding.
    Williams LT; Jarett L; Lefkowitz RJ
    J Biol Chem; 1976 May; 251(10):3096-104. PubMed ID: 942608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of beta 1- and beta 2-adrenoceptors in the rabbit heart: quantitative analysis of the regional distribution by (-)-3H-dihydroalprenolol binding.
    Brodde OE; Leifert FJ; Krehl HJ
    J Cardiovasc Pharmacol; 1982; 4(1):34-43. PubMed ID: 6176797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.